Logo

Medtronic Reports Results of PRODIGY Study in Patients with Opioid-Induced Respiratory Depression (OIRD)

Share this

Medtronic Reports Results of PRODIGY Study in Patients with Opioid-Induced Respiratory Depression (OIRD)

Shots:

  • The PRODIGY (Prediction of Opioid-induced respiratory Depression In patients monitored by capnography) study reports results of the PRODIGY score in 1-496 patients at high risk of developing respiratory compromise (OIRD)across 16 sites in the US- Europe and Asia
  • The PRODIGY study demonstrated 76% identification of patients with confirmed respiratory depression (AUC=0.7620)- presented at Society of Critical Care Medicine's (SCCM) 48th Critical Care Congres
  • PRODIGY OIRD risk prediction tool is used to identify patients at the risk of OIRD and guide early intervention using continuous capnography-based monitoring to improve patient safety

Ref: Medtronic | Image: Twitter

Click here to­ read the full press release 

Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions